ADAG — ADAGENE INC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying ADAG?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
67
Institutional Conviction
Mixed · 2 buying vs 1 selling last quarter
49
Macro Tailwind
Macro conditions are a headwind for this sector
38
Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their ADAG position last quarter, 2 bought and 1 sold (67% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).

Supporting evidence
  • +2 tracked investors added or increased positions last quarter (Izzy Englander, Steve Cohen)
  • +3 tracked investors reported holding ADAG at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
  • −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.

About ADAGENE INC (ADAG)

ADAGENE INC (ADAG) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $2M. Across recent filings, tracked investors recorded 5 new positions, 1 increased, 1 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ADAG

86
/100
Strong Institutional Accumulation
Added / Increased6
Reduced1
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track ADAG

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

ADAG Ownership Composition

How ADAGENE INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
100% of tracked value
Institutions
3
tracked investors
Total Reported
$604.6K
combined 13F value
Types1
  • Multi-Strategy / Quant100.0%
Multi-Strategy / Quant(3)
100.0%

Tracked investors currently reporting ADAG

  • Ken GriffinSep 30, 2026
    Citadel Advisors
    Shares
    106K
    Value
    $339.3K
    % Portfolio
    0.00%
  • Izzy EnglanderSep 30, 2026
    Millennium Management
    Shares
    72.8K
    Value
    $233.1K
    % Portfolio
    0.00%
  • Steve CohenSep 30, 2026
    Point72 Asset Management
    Shares
    10.1K
    Value
    $32.2K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold ADAG?
3 tracked institutional investors disclosed a position in ADAG (ADAGENE INC) in their most recent 13F filing.
Who is the largest institutional holder of ADAG?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in ADAG, valued at $2M.
Did institutional ownership of ADAG increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 1 increased, 1 reduced, and 0 fully exited ADAG.
Where does this ADAG ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.